BIOLOGICAL CANCER TREATMENT COMPOSITION OF NATURAL KILLER CELL-DERIVED EXOSOMES WITH ENHANCED CYTOKINE ACTIVITY, AND USE THEREOF

The present invention relates to a biological cancer treatment composition of natural killer cell-derived exosomes with enhanced cytokine activity, and a use thereof, and more specifically, to a cancer treatment composition containing natural killer cell (NK cell)-derived exosomes pretreated with cy...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, In Young, CHOI, Eunpyo, PARK, Jong-oh, KIM, Ho Yong, CHOI, You Hee, SONG, Hyeong-Woo
Format Patent
LanguageEnglish
French
Korean
Published 21.03.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a biological cancer treatment composition of natural killer cell-derived exosomes with enhanced cytokine activity, and a use thereof, and more specifically, to a cancer treatment composition containing natural killer cell (NK cell)-derived exosomes pretreated with cytokines, and a method for treating cancer, wherein the composition can be independently used for treating cancer or used for treating various cancers. La présente invention concerne une composition biologique de traitement du cancer d'exosomes dérivés de cellules tueuses naturelles présentant une activité de cytokine améliorée, et son utilisation, et plus précisément, une composition de traitement du cancer contenant des exosomes dérivés de cellules tueuses naturelles (cellules NK) prétraitées avec des cytokines, et une méthode de traitement du cancer, la composition pouvant être utilisée indépendamment pour le traitement du cancer ou utilisée pour le traitement de divers cancers. 본 발명은 사이토카인 활성 강화된 자연살해세포 유래 엑소좀의 암 치료용 생물학적 조성물 및 이의 용도에 관한 것으로, 더욱 상세하게는, 사이토카인을 통해 전처리된 자연살해세포 (natural killer cells; NK cells) 유래의 엑소좀을 포함하는 암 치료용 조성물 및 치료 방법에 관한 것으로, 독립적으로 암의 치료에 사용되거나, 다양한 암의 치료에 사용될 수 있다.
Bibliography:Application Number: WO2023KR11223